Dr. Christina Brennan Joins SCRS Leadership Council
Contact:
SCRS Communications
Society for Clinical Research Sites
410.696.5080
communications@myscrs.org
FOR IMMEDIATE RELEASE
Dr. Christina Brennan Joins SCRS Leadership Council
Hanover, MD, June 22, 2020 – Today, the Society for Clinical Research Sites (SCRS) announced that Christina Brennan, MD, MBA, VP of Clinical Research for Northwell Health, has joined the organization’s Leadership Council. In this role, Dr. Brennan will join other members of the Leadership Council, which includes sites, sponsors, CROs and professional solution providers, to help guide SCRS’s strategy to carry out its mission of unifying the voice of the global clinical research site community for greater site sustainability.
Dr. Brennan has devoted her career to clinical research and currently serves as Northwell Health’s vice president of clinical research. Committed to the advancement of science and medicine, Dr. Brennan has more than 20 years of extensive clinical research experience, including over 15 years in clinical research management roles. She is on the board of trustees of the Association of Clinical Research Professionals. She is the immediate past president of the NY Metropolitan Chapter of the Association of Clinical Research Professionals.
Dr. Brennan is an active member of the Clinical Trial Transformation Initiative (CTTI), through Duke University and the FDA, where she actively sits on some of their committees. She also sits on the oncology advisory board and technology site advocacy group with the Society for Clinical Research Sites (SCRS). She is also an active member of the Women in Bio and the American College of Healthcare Executives. She is an adjunct professor at Yeshiva University’s graduate program and has authored chapters in textbooks, coauthored many manuscripts and abstracts, and presented at numerous scientific and research meetings.
“I am honored to join the SCRS Leadership Council. I believe in the mission of SCRS and I am proud to be the voice of the sites,” said Dr. Brennan. “Now more than ever, sites need the support of SCRS. I look forward to collaborating with my fellow leaders on this council.”
“Dr. Brennan has provided thoughtful guidance for SCRS’ strategy and development related to oncology and technology,” shared SCRS COO Allyson Small. “Dr. Brennan’s years of experience working directly with the pharmaceutical industry and regulatory leaders will help us continue to bring the voice of the sites into transformational conversations.”
###
About SCRS
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.
